trending Market Intelligence /marketintelligence/en/news-insights/trending/aVQPLOV6zh5vBZ99oIC3Ew2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Midatech Pharma to raise $3M in registered direct offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Midatech Pharma to raise $3M in registered direct offering

Midatech Pharma PLC agreed to sell 3 million American depositary shares to an institutional investor at $1 apiece in a registered direct offering.

The Cardiff, U.K.-based biotechnology company expects to generate $3 million in gross proceeds from the transaction. Each ADS represents 20 ordinary shares of the company.

Additionally, the institutional investor in the offering will receive unregistered warrants to buy up to 3 million ADSs in a concurrent private placement. The warrants are exercisable for $1.25 apiece and will expire in five and a half years.

Closing of the offering will occur on or about Oct. 25, subject to closing conditions.

Midatech applied for the admission of the 60 million new ordinary shares to trading on the London Stock Exchange's AIM, expected to occur Oct. 29.

H.C Wainwright & Co. is acting as the exclusive placement agent in the offering.